StockData
CVS HEALTH Corp logo

CVS HEALTH Corp (CVS) operating KPIs

CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/3016% above fair value
$90.25−0.08 (-0.09%)

Close on Oct 30, 2026Market cap $115.43BP/E 23.9Yield 2.95%

KPIs

Operating metrics that drive Cvs Health's business · fiscal year ends December 31

The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.

Add to chartMetric
Q3 2026
2026-09-30
Q2 2026
2026-06-30
Q1 2026
2026-03-31
Q4 2025
2025-12-31
Q3 2025
2025-09-30
Q2 2025
2025-06-30
Q1 2025
2025-03-31
Q4 2024
2024-12-31
Q3 2024
2024-09-30
Q2 2024
2024-06-30
Q1 2024
2024-03-31
Q4 2023
2023-12-31
Health Care Benefits (Aetna) — Total Medical Membership7
26,023.0026,005.0026,591.0026,703.0026,721.0027,079.0027,095.0027,148.0026,970.0026,770.0025,659.00
Total Insured Medical Membership
9,829.009,767.0010,868.0011,001.0011,069.0011,417.0012,514.0012,557.0012,428.0012,212.0011,128.00
Total ASC (Self-Insured) Medical Membership
16,194.0016,238.0015,723.0015,702.0015,652.0015,662.0014,581.0014,591.0014,542.0014,558.0014,531.00
Commercial Medical Membership (Total)2
18,320.0018,334.0018,797.0018,850.0018,859.0019,211.0018,851.0018,906.0018,801.0018,846.0018,339.00
Commercial — Insured
2,487.002,462.003,447.003,536.003,608.003,961.004,691.004,751.004,702.004,735.004,252.00
Commercial — ASC
15,833.0015,872.0015,350.0015,314.0015,251.0015,250.0014,160.0014,155.0014,099.0014,111.0014,087.00
Medicare Advantage Medical Membership (Insured / Total)
4,202.004,175.004,267.004,266.004,240.004,220.004,447.004,438.004,342.004,205.003,460.00
Medicare Supplement Membership (Insured / Total)
1,176.001,192.001,202.001,221.001,236.001,253.001,282.001,291.001,294.001,300.001,343.00
Medicaid Medical Membership (Total)2
2,325.002,304.002,325.002,366.002,386.002,395.002,515.002,513.002,533.002,419.002,517.00
Medicaid — Insured
1,964.001,938.001,952.001,978.001,985.001,983.002,094.002,077.002,090.001,972.002,073.00
Medicaid — ASC
361.00366.00373.00388.00401.00412.00421.00436.00443.00447.00444.00
Medicare Part D Standalone Prescription Drug Plan (PDP) Membership
3,870.003,889.004,041.004,056.004,065.004,094.004,882.004,898.004,903.004,947.006,081.00
Health Care Benefits — Medical Benefit Ratio (MBR %)(%)
87.4%84.6%94.8%92.8%89.9%87.3%94.8%95.2%89.6%90.4%88.5%
Health Care Benefits — Days Claims Payable (DCP, days)(days)
4243394341434445434546
Health Services (Caremark PBM) — Pharmacy Claims Processed (30-Day Equivalent)(M)
473465492476469464499484471463601
Health Services (Caremark PBM) — Generic Dispensing Rate (Total %, through FY2024)(%)
86.1%86.8%88.2%88.3%86.2%
Pharmacy & Consumer Wellness (CVS Pharmacy) — Prescriptions Filled (30-Day Equivalent)(M)2
457451474461438436446432420418432
Same-Store Prescription Volume Growth (%, 30-Day Equivalent)(%)
7.0%6.8%9.7%8.9%6.4%6.7%5.9%9.1%6.5%5.8%4.4%
Pharmacy & Consumer Wellness — Generic Dispensing Rate (%, through FY2024)(%)
87.4%88.2%90.1%90.1%86.6%
Pharmacy & Consumer Wellness — Total Same-Store Sales Growth (% YoY)(%)2
2.6%2.8%16.0%14.3%15.4%14.2%10.2%15.5%6.4%5.3%11.3%
Pharmacy Same-Store Sales Growth (% YoY)(%)
2.9%3.1%19.3%16.8%18.1%17.7%13.0%19.5%9.1%7.3%15.5%
Front Store Same-Store Sales Growth (% YoY)(%)
1.0%1.2%0.5%1.5%3.4%-0.3%-1.2%-1.1%-4.0%-2.2%-3.1%
Health Care Benefits (Aetna) — Total Segment Revenues($M)3
37,53835,97136,29335,99336,25834,81032,95832,99632,47532,23626,726
Health Care Benefits — Premium Revenues (Total)($M)2
35,11933,79234,01833,73934,18432,80830,90230,91430,65430,37925,065
Government Premiums (Medicare Advantage, Medicare Supplement, PDP & Medicaid)($M)
28,49427,78326,56225,96825,93024,90222,16422,33122,22221,71617,414
Commercial Insured Premiums($M)
6,6256,0097,4567,7718,2547,9068,7388,5838,4328,6637,651
Health Care Benefits — Services Revenue (ASC Fees)($M)
1,9111,7171,8001,7411,6671,6151,6591,6591,5211,5041,452
Health Care Benefits — Net Investment Income($M)
508462475513407387397423300353209
Health Care Benefits — Adjusted Operating Income (Loss)($M)6
2,4263,041-6763141,3081,993-439-924938732676
Health Care Benefits — Adjusted Operating Margin (%)(%)
6.5%8.5%-1.9%0.9%3.6%5.7%-1.3%-2.8%2.9%2.3%2.5%
Health Care Benefits — GAAP Operating Income (Loss)($M)
2,1912,806-936531,0021,674-757-1,229574428266
Health Care Benefits — GAAP Operating Margin (%)(%)
5.8%7.8%-2.6%0.1%2.8%4.8%-2.3%-3.7%1.8%1.3%1.0%
Health Care Benefits — Health Care Costs (Benefit Costs)($M)
30,69228,57932,25331,31930,74028,63729,30029,44327,45827,45822,175
Health Care Benefits — Operating Expenses($M)
4,6554,5864,9764,6214,5164,4994,4154,7824,4434,3504,285
Health Care Benefits — Operating Expense Ratio (% of Revenues)(%)
12.4%12.7%13.7%12.8%12.5%12.9%13.4%14.5%13.7%13.5%16.0%
Health Services (Caremark PBM & Care Delivery) — Total Segment Revenues($M)6
51,79548,23751,24449,26646,45343,46247,02044,12942,17140,28549,146
Health Services Revenue by Channel — Pharmacy Network($M)
26,61725,14927,58826,40824,66523,11425,20224,13621,84820,46429,668
Health Services Revenue by Channel — Mail & Specialty (Mail Choice)($M)
22,57720,50621,26320,39219,61118,06818,75017,21417,65117,26217,614
Health Services Revenue by Channel — Other (Care Delivery, Clinical & GPO)($M)
2,6022,5822,3832,4672,1802,2662,7802,7802,6742,5591,865
Health Services Revenue by Channel — Net Investment Income (Loss)($M)
-110-1-314288-1-2-1
Health Services Revenue by Source — Products($M)
49,21645,72648,80246,76744,22341,13544,01941,20839,49237,71747,237
Health Services Revenue by Source — Services($M)
2,5802,5112,4322,5002,2332,3132,7132,9222,6812,5681,910
Health Services — Adjusted Operating Income($M)9
1,7331,4891,9232,0501,5751,6031,7612,2041,9151,3631,860
Health Services — Adjusted Operating Margin (%)(%)
3.3%3.1%3.8%4.2%3.4%3.7%3.7%5.0%4.5%3.4%3.8%
Health Services — GAAP Operating Income($M)
1,6031,3471,790-3,8991,1021,2271,9032,0551,7661,2131,710
Health Services — GAAP Operating Margin (%)(%)
3.1%2.8%3.5%-7.9%2.4%2.8%4.0%4.7%4.2%3.0%3.5%
Health Services — Gross Profit($M)
2,5372,2162,6402,7452,2722,3002,6832,8122,6152,0522,535
Health Services — Gross Margin (%)(%)
4.9%4.6%5.2%5.6%4.9%5.3%5.7%6.4%6.2%5.1%5.2%
Health Services — Cost of Products Sold($M)
47,90844,71947,20945,23043,08040,11543,35840,38138,76537,53245,999
Health Services — Health Care Costs (Oak Street Capitated Medical Costs)($M)
1,3501,3021,3951,2911,1011,047979936791701612
Health Services — Operating Expenses($M)
9348698509191,1701,073780757849839825
Health Services — Operating Expense Ratio (% of Revenues)(%)
1.8%1.8%1.7%1.9%2.5%2.5%1.7%1.7%2.0%2.1%1.7%
Pharmacy & Consumer Wellness (CVS Pharmacy) — Total Segment Revenues($M)5
33,81631,98937,66036,21433,58131,91233,51432,42329,83828,72531,185
Pharmacy & Consumer Wellness Revenue by Line — Pharmacy($M)
27,78126,12331,37530,42827,63126,07627,22426,66624,01322,78424,740
Pharmacy & Consumer Wellness Revenue by Line — Front Store($M)
5,4075,2595,6565,1925,3685,2435,6755,1965,2815,3705,861
Pharmacy & Consumer Wellness Revenue by Line — Other (MinuteClinic / Clinical)($M)
628607629594582593615561544571585
Pharmacy & Consumer Wellness Revenue by Source — Products($M)
33,15231,33936,84535,50332,94231,28532,83331,82329,25228,12030,534
Pharmacy & Consumer Wellness Revenue by Source — Services($M)
664650815711639627681600586605652
Pharmacy & Consumer Wellness — Adjusted Operating Income($M)8
1,4751,1971,9111,4781,3381,3131,7581,5961,2431,1772,027
Pharmacy & Consumer Wellness — Adjusted Operating Margin (%)(%)
4.4%3.7%5.1%4.1%4.0%4.1%5.2%4.9%4.2%4.1%6.5%
Pharmacy & Consumer Wellness — GAAP Operating Income($M)
1,4111,1341,8461,4147368641,6947841,1791,1131,961
Pharmacy & Consumer Wellness — GAAP Operating Margin (%)(%)
4.2%3.5%4.9%3.9%2.2%2.7%5.1%2.4%4.0%3.9%6.3%
Pharmacy & Consumer Wellness — Gross Profit($M)
6,5346,1997,0826,5676,0276,1086,8046,3916,0035,9657,039
Pharmacy & Consumer Wellness — Gross Margin (%)(%)
19.3%19.4%18.8%18.1%17.9%19.1%20.3%19.7%20.1%20.8%22.6%
Pharmacy & Consumer Wellness — Cost of Products Sold($M)
27,28225,79030,57829,64727,55425,80426,71026,03223,83522,76024,146
Pharmacy & Consumer Wellness — Operating Expenses($M)
5,1235,0655,2365,1535,2915,2445,1104,8604,8244,8525,078
Pharmacy & Consumer Wellness — Operating Expense Ratio (% of Revenues)(%)
15.1%15.8%13.9%14.2%15.8%16.4%15.2%15.0%16.2%16.9%16.3%
Consolidated — Adjusted Operating Income($M)3
5,1575,1502,5973,4593,8084,5792,7282,5473,7442,9574,227
Consolidated — Adjusted Income Attributable to CVS Health($M)
3,3243,2921,3872,0372,3042,8441,5061,3692,3061,6572,738
Consolidated — Adjusted Diluted EPS ($/share)($)
2.582.571.091.601.812.251.191.091.831.312.12
Consolidated — Intersegment Revenue Eliminations($M)
-17,200-15,897-19,626-18,735-17,473-15,729-15,865-14,262-13,361-12,924-13,319
Health Care Costs Payable, Net of Reinsurance (Actuarial Rollforward)($M)6
16,20315,40415,32915,30014,29614,56514,98414,52113,85014,38712,067
IBNR (Incurred But Not Reported) Claims Liability($M)
10,60010,60010,60010,40010,70011,00010,60011,000
Reinsurance Recoverables on Unpaid Claims($M)
112132909410311481655945
Total Incurred Health Care Costs in Reserve Rollforward($M)2
31,40429,28133,70432,12530,80328,64230,13129,18127,78227,73322,450
Incurred Health Care Costs — Current Year($M)
31,55330,37433,76032,15131,05230,29330,23329,36427,96528,21222,456
Incurred Health Care Costs — Prior Years Development (Favorable / Unfavorable)($M)
-149-1,093-56-26-249-1,651-102-183-183-479-6
Claims Paid — Current Year Incurred($M)
29,75218,25533,33630,89629,47919,31230,22728,13826,95516,26322,577
Claims Paid — Prior Years Incurred($M)
85310,9513392251,5939,749-5593721,3649,150378
Health Care Costs Payable Assumed in Acquisitions / Dispositions($M)
000
Direct Premiums Earned (Reinsurance Schedule)7
Premiums Receivable, Net($M)
6,3957,6335,7534,8785,8856,2104,7313,9424,4305,4203,714
Deferred Acquisition Costs (DAC) Balance($M)2
1,9171,8811,8371,7941,7471,6901,6271,5601,502
DAC Capitalized Additions($M)
127127129133139134137134134
DAC Amortization Expense($M)
918386868271707669
Statutory Capital & Surplus Required by Insurance Regulators($M)
11,71011,6919,011
Maximum Statutory Dividend Capacity Without Prior Regulatory Approval($M)
3,7881,5613,098
Self-Insurance Accrual Liability($M)
1,2001,1001,100
Separate Account Policyholder Deposits($M)
220226206236303231229201203
Separate Account Policyholder Benefits Paid($M)
239241230243272257226223224
Available-for-Sale (AFS) Debt Securities — Fair Value($M)7
29,34928,39128,71827,83526,55426,04426,03326,49023,83122,62621,713
AFS Debt Securities — Amortized Cost($M)
29,56428,59328,60027,70526,65626,34526,56226,43324,54823,30822,282
AFS Debt Securities — Gross Unrealized Gains($M)
207245449462347246178510146191267
AFS Debt Securities — Gross Unrealized Losses($M)
422447331332449547707453863873836
AFS Debt Securities Maturing Within 1 Year (Fair Value)($M)
1,1688528178389631,1897618161,3491,2451,230
AFS Debt Securities Maturing in 1 to 5 Years (Fair Value)($M)
11,75211,53411,69911,51211,07010,67010,51010,5298,7847,8367,390
AFS Debt Securities Maturing in 5 to 10 Years (Fair Value)($M)
5,8805,6855,3824,7834,5644,3854,5784,8904,2884,4634,204
AFS Debt Securities Maturing After 10 Years (Fair Value)($M)
2,9782,9002,8472,7122,5612,7102,9093,0643,3103,7033,802
Total Lease Cost (Note 7 Leases)1
Undiscounted Future Operating Lease Payments (Total)($M)8
19,38721,18922,853
Operating Lease Payments Due in Year 1($M)
2,6262,6832,716
Operating Lease Payments Due in Year 2($M)
2,4752,5282,559
Operating Lease Payments Due in Year 3($M)
2,3002,3432,369
Operating Lease Payments Due in Year 4($M)
2,0312,1672,181
Operating Lease Payments Due in Year 5($M)
1,7891,9112,024
Operating Lease Payments Due After Year 5($M)
8,1669,55711,004
Total Finance Lease Liabilities($M)
1,3261,3571,3601,3731,3791,391
Finance Lease Right-of-Use Assets, Net($M)
1,0941,1401,229
Long-Term Debt Maturing After Year 5 (Note 10 Borrowings)($M)5
43,29943,55841,685
Long-Term Debt Maturing in Year 1($M)
4,0073,5592,705
Long-Term Debt Maturing in Year 2($M)
3,3794,0073,785
Long-Term Debt Maturing in Year 3($M)
5,0083,3794,008
Long-Term Debt Maturing in Year 4($M)
3,7585,0073,379
Long-Term Debt Maturing in Year 5($M)
4,2583,7585,007
Gross Finite-Lived & Indefinite-Lived Intangible Assets (Note 6)($M)8
44,36544,27144,166
Accumulated Amortization of Intangible Assets($M)
18,85716,94814,932
Indefinite-Lived Intangible Assets (Tradenames)($M)
10,49810,49810,498
Intangible Asset Amortization Expense($M)
431442483500494499503507507508509
Estimated Intangible Amortization — Year 1($M)
1,7171,9812,011
Estimated Intangible Amortization — Year 2($M)
1,6041,7041,964
Estimated Intangible Amortization — Year 3($M)
1,3301,5901,687
Estimated Intangible Amortization — Year 4($M)
1,2521,3161,580
Estimated Intangible Amortization — Year 5($M)
1,2191,2391,306
Trade Accounts Payable & Pharmacy Working Capital Balances($M)4
17,16716,92217,64117,76417,25816,53415,89215,71314,41613,71714,897
Contract Assets, Current (PBM Rebates & Medicare Part D)($M)
12,98512,51110,56311,22110,46510,4509,8819,8849,79310,58611,908
Contract Liabilities, Current($M)
62586165144174128117149
Other Receivables, Net (Manufacturer Rebates & CMS)($M)
6,1116,7047,8999,9799,0538,7607,9666,7324,6343,5303,894
Allowance for Credit Losses on Accounts Receivable($M)
169200182178374392407346355402343
BEA U.S. Personal Consumption Expenditures: Health Care Services (SAAR $B)5
3,790.303,699.903,667.003,614.903,529.803,464.703,417.803,358.203,288.203,244.403,159.40
BEA Real PCE: Health Care Quantity Index (2017=100)(×)
135.90133.60133.60132.70130.40129.00127.90126.70124.80123.80121.50
Census QSS Quarterly Revenue: Ambulatory Health Care Services (NAICS 621)($M)
414,886395,174407,176398,164389,960373,423380,950366,854362,208347,178347,128
Census QSS Quarterly Revenue: Hospitals (NAICS 622)($M)
47,89646,67446,83446,29545,37045,35845,28443,77843,50543,70943,264
Census QSS Quarterly Revenue: Medical and Diagnostic Laboratories (NAICS 6215)($M)
20,52819,56919,99719,67719,71818,72219,10418,89318,48317,96317,943
Census QSS Quarterly Revenue: Outpatient Care Centers (NAICS 6214)($M)
45,10844,02245,30042,79741,83240,03040,60237,89737,22736,08737,030
Peer Benchmark — UnitedHealth Group (UNH): Total Revenues($M)4
112,032111,721113,215113,161111,616109,575100,807100,82098,85599,79694,427
UnitedHealth Group (UNH) — Premiums Revenue($M)
86,95687,56188,81188,97987,90586,53476,48377,44276,89777,98873,228
UnitedHealth Group (UNH) — Medical & Policyholder Benefits Expense($M)
75,35873,48982,04179,95878,58573,41167,03565,95765,45865,73562,231
UnitedHealth Group (UNH) — GAAP Operating Income($M)
7,9918,9903804,3155,1509,1197,7738,7087,8757,9317,689
UnitedHealth Group (UNH) — Medical Costs Payable($M)
38,93039,65939,33740,18138,42737,13634,22433,95132,54734,03232,395
Peer Benchmark — The Cigna Group (CI / Express Scripts): Total Revenues($M)3
71,66868,49472,47269,74867,17865,50265,64963,69460,52357,25551,114
The Cigna Group (CI) — Premiums Revenue($M)
9,8599,8129,2889,0819,15612,73611,50311,43611,45411,60311,175
The Cigna Group (CI) — Medical & Policyholder Benefits Expense($M)
8,4307,9248,2607,8427,74910,49810,1669,5279,5159,4409,280
The Cigna Group (CI) — GAAP Operating Income($M)
2,6762,3582,3452,5782,3061,9712,1732,5762,4122,2562,060
Peer Benchmark — Elevance Health (ELV / Carelon, through Q3 2026): Total Revenues($M)4
51,42950,47450,18149,74750,71149,77648,89145,44245,10643,88642,57742,647
Elevance Health (ELV) — Premiums Revenue($M)
41,70441,27941,02440,69041,79141,27140,88736,24536,80935,41635,69635,138
Elevance Health (ELV) — Benefit Expense($M)
37,77937,02435,61538,06538,14036,70635,31233,50032,94930,57230,54631,334
Elevance Health (ELV) — GAAP Operating Income($M)
1,2691,7632,0863091,2952,4253,1706731,4082,7653,0161,284
Elevance Health (ELV) — Medical Claims Payable($M)
18,43818,46318,42517,08417,14817,15516,81215,74615,34615,20416,45916,111
Peer Benchmark — Humana Inc. (HUM / CenterWell): Total Revenues($M)4
39,64832,51532,64932,38832,11229,21329,39729,54029,61126,462
Humana Inc. (HUM) — Premiums Revenue($M)
37,70930,88430,71130,71630,51427,75027,95128,14228,26125,128
Humana Inc. (HUM) — Benefits Expense($M)
33,70728,72127,99127,56526,53525,38125,12025,03925,12422,782
Humana Inc. (HUM) — GAAP Operating Income($M)
1,754-8084001,0982,014-5437281,1411,236-348
Humana Inc. (HUM) — Benefits Payable($M)
12,6919,96710,08811,06011,45110,44011,12511,44611,72910,241
Peer Benchmark — Centene Corporation (CNC, through Q3 2026): Total Revenues($M)3
50,64753,57949,94449,72549,69048,74246,62040,80542,02339,83640,40739,460
Centene Corporation (CNC) — Medical Costs($M)
41,12839,02938,30341,48940,90238,80836,50331,80932,20130,76530,93230,634
Centene Corporation (CNC) — GAAP Operating Income($M)
-3071,1981,861-1,745-6,954-4581,5341756651,2291,106-194
Centene Corporation (CNC) — Medical Claims Liability($M)
21,49520,26220,62720,54421,49320,11719,91118,30817,99518,17318,10918,000
Peer Benchmark — Molina Healthcare (MOH, through Q3 2026): Total Revenues($M)3
11,08210,87410,79611,37511,47711,42711,14710,49910,3409,8809,9319,048
Molina Healthcare (MOH) — Premium Revenue($M)
10,45710,24410,17210,71510,84110,86810,6289,9839,6949,4469,5048,362
Molina Healthcare (MOH) — GAAP Operating Income($M)
10614583-162137373433380467434426316
Molina Healthcare (MOH) — Medical Claims & Benefits Payable($M)
4,9884,8414,9414,8874,8444,8854,8044,6404,7324,5774,5714,204
Peer Benchmark — HCA Healthcare (HCA) & Labcorp (LH): Provider & Lab Revenues($M)2
19,10919,51319,16118,60518,32118,28517,48717,49217,33917,303
Labcorp Holdings (LH) — Total Revenues($M)
3,7313,5383,5163,5643,5273,3453,3293,2823,2213,1773,033
Labcorp Holdings (LH) — GAAP Operating Income($M)
452381268397394326216254295321-123
DB Segment Context — Health Care Benefits Segment Revenue($M)1
37,53835,97136,29335,99336,25834,81032,95832,99632,47532,23626,726
DB Segment — Health Care Benefits D&A($M)
348340380375419405403407397392
DB Segment Context — Health Services (formerly Pharmacy Services) Segment Revenue($M)1
51,79548,23751,24449,26646,45343,46247,02044,12942,17140,28549,146
DB Segment — Health Services D&A($M)
251258258260260261267267264261
DB Segment Context — Pharmacy & Consumer Wellness (formerly Retail/LTC) Segment Revenue($M)1
33,81631,98937,66036,21433,58131,91233,51432,42329,83828,72531,185
DB Segment — Pharmacy & Consumer Wellness D&A($M)
415406404396389384379387389388
DB Consolidated — Total Revenues($M)12
106,096100,426105,693102,87198,91594,58897,71095,42891,23488,43793,813
DB Consolidated — Premiums Earned($M)
35,11733,79134,01733,71934,19532,82030,91330,92530,66730,39125,075
DB Consolidated — Net Investment Income($M)
641574594632487520755550394454268
DB Consolidated — Cost of Revenue($M)
58,86255,44459,06057,04554,00551,05755,26852,94849,99848,07357,419
DB Consolidated — Policyholder & Medical Benefits($M)
31,48529,35833,06632,02031,31729,13529,54329,92227,85327,80322,518
DB Consolidated — Operating Income (GAAP)($M)
4,7034,6802,112-3,2072,3813,3742,3688323,0452,2713,373
DB Consolidated — Interest Expense($M)
757774787784763785758752732716690
DB Consolidated — Income Before Income Taxes($M)
3,9773,9381,354-3,4821,6472,6172,1261052,3371,5802,705
DB Consolidated — Income Tax Provision($M)
982981-1,56950863483550334569456658
DB Consolidated — Net Income Attributable to CVS Health($M)
2,9792,9432,943-3,9751,0211,7791,644871,7701,1132,046
DB Consolidated — Diluted EPS (GAAP)($)
2.312.30-3.130.801.410.071.410.88
DB Consolidated — Weighted Average Diluted Shares(M)
1,2871,2791,2691,2701,2641,2591,2591,267
DB Consolidated — Cash Dividends Declared per Share($)
0.670.670.670.670.670.670.670.670.670.670.60
DB Consolidated Balance Sheet — Total Assets($M)11
253,768252,974253,538255,327258,343255,585253,215252,427252,481249,743249,728
DB Balance Sheet — Accounts Receivable, Net($M)
40,30940,99239,77943,85740,65139,62536,46936,17932,38532,21735,227
DB Balance Sheet — Inventories($M)
17,62217,77019,24618,96217,44717,38518,10717,64916,06816,34618,025
DB Balance Sheet — Property and Equipment, Net($M)
13,16813,03713,08312,83812,82512,85612,99312,72813,03213,03713,183
DB Balance Sheet — Operating Lease Right-of-Use Assets($M)
14,45114,74114,97315,27115,51215,70415,94416,23116,90117,04517,252
DB Balance Sheet — Goodwill($M)
85,47885,47885,47885,47891,20391,20391,27291,27291,27291,27291,272
DB Balance Sheet — Intangible Assets, Net($M)
24,64425,07025,50825,98426,22426,57027,32327,81728,31128,77029,234
DB Balance Sheet — Accrued Expenses and Other Liabilities($M)
22,47722,25822,38723,41523,10122,36920,81020,17421,16322,35023,515
DB Balance Sheet — Operating Lease Liabilities($M)
15,38016,65017,775
DB Balance Sheet — Total Liabilities($M)
173,869175,337178,156182,217180,792178,475177,485177,321177,370175,593173,092
DB Balance Sheet — Total Shareholders' Equity($M)
79,89977,63775,38273,11077,55177,11075,73075,10675,11174,15076,636
DB Balance Sheet — Common Shares Outstanding(M)
1,2781,2731,2711,2701,2671,2621,2601,2581,2561,2521,288
DB Consolidated Cash Flow — Operating Cash Flow($M)6
6,3454,2493,3907961,8974,5561,860-7453,0894,903-2,636
DB Cash Flow — Capital Expenditures (Additions to Property & Equipment)($M)
691849784698607743768670638705911
DB Cash Flow — Depreciation and Amortization($M)
1,1261,1151,1471,1341,1711,1541,1471,1611,1511,1381,134
DB Cash Flow — Stock-Based Compensation($M)
176266135138136126137133133137127
DB Cash Flow — Acquisitions (Net of Cash Acquired)($M)
4572901192010124825120
DB Cash Flow — Dividends Paid($M)
878847845846866840838837858840779
DB Cash Flow — Share Repurchases($M)
-0-0-0-0-0133,0271

40 metrics have no data in the last 12 quarters — .

Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).

Methodology and excluded metrics
  • Fiscal calendar: CVS Health Corporation operates on a calendar fiscal year ending December 31 (Q1 ends Mar 31, Q2 ends Jun 30, Q3 ends Sep 30, Q4 ends Dec 31). Latest reported company period: Q2 2026 (ended June 30, 2026, filed August 5, 2026 on Form 8-K and Form 10-Q) and Full-Year FY2025 (ended December 31, 2025, filed February 10, 2026 on Form 8-K and Form 10-K). Industry monthly FRED series extend through September 2026 (2026-09) and Managed Care peer XBRL benchmarks (ELV, CNC, MOH) extend through Q3 2026 (FY2026Q3).
  • Q1 2023 Segment Realignment: Effective Q1 2023, CVS Health realigned its segments into Health Care Benefits (Aetna), Health Services (formerly Pharmacy Services, adding Oak Street Health, Signify Health, and MinuteClinic care delivery), and Pharmacy & Consumer Wellness (formerly Retail/LTC, adding mail/specialty fulfillment support and discontinuing the former Maintenance Choice segment reporting practice). Comparative FY2021–FY2022 figures were retrospectively recast in the FY2023 Form 8-K/10-K.
  • Discontinuation of Generic Dispensing Rate (GDR %): Beginning Q1 2025, CVS Health discontinued reporting Generic Dispensing Rate (GDR %) in both Health Services and Pharmacy & Consumer Wellness. Historical GDR series are preserved continuously from FY2017 through FY2024Q4 / FY2024.
  • Subsidiary Self-Reported Disclosures (Group 3): Integrates standalone SEC Form 10-K and Form 10-Q filings of Oak Street Health, Inc. (CIK 0001564406, acquired May 2, 2023), Signify Health, Inc. (CIK 0001828182, acquired March 29, 2023), and Aetna Inc. (CIK 0001122304, acquired November 28, 2018).
  • Parent-Company Standalone Evaluation (Step 3): CVS Health files consolidated US GAAP financial statements without standalone parent-company revenue/operating statements (parent registrant is a holding company with $0 direct operating revenue). Therefore, Consolidated − Standalone subtraction does not apply.
  • Strict Step 4 & Step 5 Compliance: Every cell displays an exact point figure published by CVS Health, its subsidiaries (Oak Street Health, Signify Health, Aetna), or official industry sources (CMS Medicaid Managed Care Enrollment Reports, Census/BLS/BEA via FRED, SEC XBRL peer filings), plus permitted period splits (Q4 = full year − nine months and quarterly cash flow = YTD − prior YTD, marked with formula). Bound/approximate prose figures ('approximately 9,000 retail locations', 'more than 81% of MA members in 4+ star plans' in FY2025, 'more than 3.5 million IHEs', 'approximately 500,000 patients') are excluded and cataloged in `excluded`.

Not shown because recent periods are missing (13)

  • Retail pharmacy locations count in Item 1 narrative ('approximately 9,000 retail locations' / 'more than 7,000 retail stores') — Số cận ('approximately 9,000', 'more than 7,000') — loại khỏi ô bảng theo Bước 5; đã thay bằng bảng Store Development Activity chính xác tuyệt đối trong Item 7 MD&A (8,979 cửa hàng cuối FY2025).
  • Retail stores net selling space ('approximately 71.3 million square feet') & distribution centers space ('approximately 10.0 million square feet') — Số cận ('approximately 71.3 million', 'approximately 10.0 million') — loại theo Bước 5.
  • Retail pharmacies within chains ('approximately 1,870') and clinics in Target stores ('approximately 30') — Số cận ('approximately 1,870', 'approximately 30') từ FY2019 trở đi; bảng phân rã theo bang chỉ công bố số điểm đến FY2017.
  • Medicare Advantage 4.0+ Star plan membership share in FY2025 ('more than 81%' in 4+ star plans; 'more than 63%' in 4.5-star plans) — Số cận ở kỳ FY2025 ('more than 81%', 'more than 63%') — loại điểm FY2025 theo Bước 5; giữ chuỗi số điểm chính xác FY2015–FY2024 (88% năm FY2024, 87% năm FY2023).
  • Oak Street Health patients cared for in FY2024–FY2025 ('approximately 500,000 patients') and FY2023 ('approximately 270,000 patients') — Số cận ('approximately 500,000', 'approximately 270,000') sau khi sáp nhập vào CVS — loại theo Bước 5; giữ chuỗi bệnh nhân chính xác từ hồ sơ 10-K/10-Q riêng của Oak Street Health (FY2018–FY2023Q1: 231,000 bệnh nhân).
  • Signify Health in-home health evaluations (IHEs) volume ('more than 3.5 million IHEs' in FY2025; 'more than 3 million' in FY2024) — Số cận ('more than 3.5 million') — loại theo Bước 5; giữ doanh thu Evaluations chính xác từ báo cáo 10-K/10-Q của Signify Health.
  • U.S. retail pharmacy prescription market share ('approximately 28.5%' in FY2025 10-K; 'exceeding 29%' in Q4 2025 presentation) — Số cận ('approximately 28.5%', 'exceeding 29%') — loại theo Bước 5.
  • PBM plan members ('approximately 87 million plan members') and retail network size ('approximately 63,000 retail pharmacies') — Số cận ('approximately 87 million', 'approximately 63,000') — loại theo Bước 5.
  • Walk-in and primary care medical clinics ('more than 1,000 clinics' / 'more than 800 MinuteClinic locations') — Số cận ('more than 1,000', 'more than 800') — loại theo Bước 5.
  • Total workforce headcount ('over 300,000 colleagues', 'approximately 73% full-time') and training hours ('approximately 16 million hours') — Số cận ('over 300,000', 'approximately 73%', 'approximately 16 million') — loại theo Bước 5.
  • Health Services retail co-payments included in segment revenue ('approximately $2.1 billion' in Q4 2025; '$10.9 billion' in FY2025) — Số cận ('approximately $2.1 billion') trong chú thích chân trang — loại theo Bước 5.
  • Full-Year 2026 Guidance ranges (Revenues 'At least $414.0B', Adjusted EPS '$7.90 to $8.10', Medical Membership '~26.0M', MBR '89.75% ±25 bps') — Số cận / khoảng hướng dẫn tương lai ('At least', '~', 'to', '±') — ghi nhận trong phần thuyết minh & README, không đưa vào ô số thực hiện theo Bước 5.
  • YTD 6-month and 9-month cumulative segment columns in Q2 and Q3 Form 8-K / 10-Q tables — Số lũy kế 6 tháng / 9 tháng — bảng đã hiển thị đầy đủ từng quý độc lập (Q1, Q2, Q3, Q4) và cả năm (FY).

Data updated 2026-10-28.

Every KPI on its own page

Full history, chart, sources and a citation for each metric

1. Core Operational KPIs — Aetna Membership & MBR, Caremark PBM Claims, CVS Pharmacy Rx & Store Footprint

2. Disaggregated Segment Revenues, Channel Mix & Adjusted Profitability (8-K / 10-Q / 10-K Supplemental)

3. Acquired Subsidiaries Self-Reported Disclosures — Oak Street Health, Signify Health & Pre-Merger Aetna

4. Actuarial Claims Rollforward, Statutory Capital, AFS Investments, Store Leases & Governance (XBRL & DEF 14A)

5. CMS Medicaid Managed Care Enrollment — U.S. National Totals & 19 CVS/Aetna State Plans

6. Industry Macro Indicators (Census Pharmacy Sales, BLS CPI/PPI/Employment) & Managed Care Peers (through Sep / Q3 2026)

7. Consolidated Financial Statements & Segment Context (PostgreSQL DB via lib.db)